D1 Capital Partners L.P. Charles River Laboratories International, Inc. Transaction History
D1 Capital Partners L.P.
- $4.55 Billion
- Q4 2024
A detailed history of D1 Capital Partners L.P. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, D1 Capital Partners L.P. holds 935,820 shares of CRL stock, worth $153 Million. This represents 3.8% of its overall portfolio holdings.
Number of Shares
935,820Holding current value
$153 Million% of portfolio
3.8%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
708Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$829 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$665 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$356 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$295 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.29B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...